These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 33601157)
1. Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of Gong MJ; Zhu CY; Zou ZJ; Han B; Huang P J Pharm Biomed Anal; 2021 Apr; 197():113964. PubMed ID: 33601157 [TBL] [Abstract][Full Text] [Related]
2. Integration of transcriptomics and metabonomics revealed the protective effects of hemp seed oil against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in mice. Gong M; Lu H; Li L; Feng M; Zou Z Food Funct; 2023 Feb; 14(4):2096-2111. PubMed ID: 36734470 [TBL] [Abstract][Full Text] [Related]
3. Soyasaponin A Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448 [TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota Plays Essential Roles in Soyasaponin's Preventive Bioactivities against Steatohepatitis in the Methionine and Choline Deficient (MCD) Diet-Induced Non-Alcoholic Steatohepatitis (NASH) Mice. Su C; Wang J; Luo H; Chen J; Lin F; Mo J; Xiong F; Zha L Mol Nutr Food Res; 2024 Feb; 68(4):e2300561. PubMed ID: 38234006 [TBL] [Abstract][Full Text] [Related]
5. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis. Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468 [TBL] [Abstract][Full Text] [Related]
6. Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet. Carril E; Valdecantos MP; Lanzón B; Angulo S; Valverde ÁM; Godzien J; Rupérez FJ J Pharm Biomed Anal; 2020 Jan; 178():112958. PubMed ID: 31718984 [TBL] [Abstract][Full Text] [Related]
7. Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway. Lv S; Zhang Z; Su X; Li W; Wang X; Pan B; Li H; Zhang H; Wang Y Front Endocrinol (Lausanne); 2022; 13():1106875. PubMed ID: 36743916 [TBL] [Abstract][Full Text] [Related]
8. Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites. Zhu M; Wang X; Wang K; Zhao Z; Dang Y; Ji G; Li F; Zhou W Front Cell Infect Microbiol; 2023; 13():1066053. PubMed ID: 36779187 [TBL] [Abstract][Full Text] [Related]
9. Butyrate Protects Mice Against Methionine-Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels. Ye J; Lv L; Wu W; Li Y; Shi D; Fang D; Guo F; Jiang H; Yan R; Ye W; Li L Front Microbiol; 2018; 9():1967. PubMed ID: 30186272 [TBL] [Abstract][Full Text] [Related]
10. A methionine-choline-deficient diet induces nonalcoholic steatohepatitis and alters the lipidome, metabolome, and gut microbiome profile in the C57BL/6J mouse. Gautam J; Aggarwal H; Kumari D; Gupta SK; Kumar Y; Dikshit M Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Dec; 1869(8):159545. PubMed ID: 39089643 [TBL] [Abstract][Full Text] [Related]
11. Aqueous extract of Polygala japonica Houtt. ameliorated nonalcoholic steatohepatitis in mice through restoring the gut microbiota disorders and affecting the metabolites in feces and liver. Liao J; Cao Y; Zhao J; Yu B; Wang Y; Li W; Li H; Lv S; Wen W; Cui H; Chen Y Phytomedicine; 2023 Sep; 118():154937. PubMed ID: 37393831 [TBL] [Abstract][Full Text] [Related]
12. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet. Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140 [TBL] [Abstract][Full Text] [Related]
13. Systems level metabolic phenotype of methotrexate administration in the context of non-alcoholic steatohepatitis in the rat. Kyriakides M; Hardwick RN; Jin Z; Goedken MJ; Holmes E; Cherrington NJ; Coen M Toxicol Sci; 2014 Nov; 142(1):105-16. PubMed ID: 25145655 [TBL] [Abstract][Full Text] [Related]
14. Rifaximin alleviates MCD diet-induced NASH in mice by restoring the gut microbiota and intestinal barrier. Shu YY; Hu LL; Ye J; Yang L; Jin Y Life Sci; 2024 Nov; 357():123095. PubMed ID: 39368771 [TBL] [Abstract][Full Text] [Related]
16. The improvement of nonalcoholic steatohepatitis by Poria cocos polysaccharides associated with gut microbiota and NF-κB/CCL3/CCR1 axis. Tan YY; Yue SR; Lu AP; Zhang L; Ji G; Liu BC; Wang RR Phytomedicine; 2022 Aug; 103():154208. PubMed ID: 35691078 [TBL] [Abstract][Full Text] [Related]
17. Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats. Saleh DO; Ahmed RF; Amin MM Appl Physiol Nutr Metab; 2017 Mar; 42(3):243-249. PubMed ID: 28177750 [TBL] [Abstract][Full Text] [Related]
18. Integrated serum metabolomics, 16S rRNA sequencing and bile acid profiling to reveal the potential mechanism of gentiopicroside against nonalcoholic steatohepatitis in lean mice. Li Z; Zhu X; Li C; Tang R; Zou Y; Liu S J Ethnopharmacol; 2024 Nov; 334():118526. PubMed ID: 38972531 [TBL] [Abstract][Full Text] [Related]
19. Yue SR; Tan YY; Zhang L; Zhang BJ; Jiang FY; Ji G; Liu BC; Wang RR Front Endocrinol (Lausanne); 2022; 13():885039. PubMed ID: 35937847 [TBL] [Abstract][Full Text] [Related]